rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

James F. Barlow

Director

Company insider

Files Form 4 as: Director, Arcturus Therapeutics Holdings; SR. VP, Corp. Controller (PAO), Allergan.

Every Form 4 they filed

In numbers

Trades disclosed
132
Buys
0
Sells
16
Bought
$0
Sold
$13.1M
Companies
2
Companies where not an officer
1
First trade
6 Feb 2006
Last trade
5 Jun 2026
Last filed
15 Jun 2026

Companies traded

Where they are an officer
AllerganOfficer · last 17 Mar 20150 buys · 16 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ARCT Arcturus Therapeutics HoldingsDirector · Biotechnology · last 5 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Jun 2026filed 15 Jun 2026ARCT Arcturus Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
5 Jun 2026filed 15 Jun 2026ARCT Arcturus Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
9 Jun 2025filed 11 Jun 2025ARCT Arcturus Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
14 Jun 2024filed 18 Jun 2024ARCT Arcturus Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code M—3,131 at $0.00filing
14 Jun 2024filed 18 Jun 2024ARCT Arcturus Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
14 Jun 2024filed 18 Jun 2024ARCT Arcturus Therapeutics HoldingsBiotechnologySEC FORM 4 Code M—3,131 at $0.00filing
1 Aug 2023filed 3 Aug 2023ARCT Arcturus Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—11,869 at $0.00filing
1 Aug 2023filed 3 Aug 2023ARCT Arcturus Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—3,131 at $0.00filing
23 Jun 2022filed 27 Jun 2022ARCT Arcturus Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
18 Jun 2021filed 22 Jun 2021ARCT Arcturus Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
22 Jun 2020filed 24 Jun 2020ARCT Arcturus Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
25 Oct 2019filed 29 Oct 2019ARCT Arcturus Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
17 Mar 2015filed 19 Mar 2015AllerganSEC FORM 4 Code D—1,873filing
17 Mar 2015filed 19 Mar 2015AllerganSEC FORM 4 Code D—1,852.33filing
17 Mar 2015filed 19 Mar 2015AllerganSEC FORM 4 Code D—644.31filing
17 Mar 2015filed 19 Mar 2015Allerganoption or derivativeSEC FORM 4 Code D—4,925filing
17 Mar 2015filed 19 Mar 2015Allerganoption or derivativeSEC FORM 4 Code D—9,500filing
17 Mar 2015filed 19 Mar 2015Allerganoption or derivativeSEC FORM 4 Code D—11,625filing
17 Mar 2015filed 19 Mar 2015Allerganoption or derivativeSEC FORM 4 Code D—14,000filing
17 Mar 2015filed 19 Mar 2015Allerganoption or derivativeSEC FORM 4 Code D—11,469filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed16

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.